Clinical outcomes

At 30 day follow-up

N = 372

At 6 month

follow-up

N = 372

At 12 month

follow-up

N = 368

At 24 month

follow-up

N = 365

Death from any cause, n (%)

2 (0.5%)

6 (1.6%)

7 (1.9%)

10 (2.7%)

Cardiac death, n (%)

2 (0.5%)

4 (1.1%)

5 (1.4%)

7 (1.9%)

Non-cardiac death, n (%)

0 (0%)

2 (0.5%)

2 (0.5%)

3 (0.8%)

Myocardial infarction, n (%)

2 (0.5%)

2 (0.5%)

3 (0.8%)

4 (1.1%)

Target lesion revascularization, n (%)

0 (0%)

2 (0.5%)

3 (0.8%)

3 (0.8%)

Target vessel revascularization, n (%)

0 (0%)

3 (0.8%)

4 (1.1%)

4 (1.1%)

Overall stent thrombosis, n (%)

2 (0.5%)

3 (0.8%)

3 (0.8%)

4 (1.1%)

Definite stent thrombosis, n (%)

1 (0.3%)

1 (0.3%)

1 (0.3%)

1 (0.3%)

Probable stent thrombosis, n (%)

1 (0.3%)

2 (0.5%)

2 (0.5%)

3 (0.8%)

Possible stent thrombosis, n (%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Major adverse cardiac events, n (%)

4 (1.1%)

8 (2.2%)

11 (3.0%)

14 (3.8%)